| Jul 1, 2022 | Source | $130.0M Series D | Breakthrough Energy Ventures, Erik Snyder | Rachel Slaybaugh, Fifth Wall, Microsoft, BlackRock, Duke Energy, Fifth Wall, Harvard Management Company, Lightsmith Group, Material Impact, WIND Ventures |
| Feb 24, 2022 | Scipher Medicine | $110.0M Other Equity | Tim Anderson | Alumni Ventures, Echo Health Ventures, Hitachi Ventures, Khosla Ventures, Laurion Capital Management, Neuberger Berman, Michael Rubin, Optum Ventures |
| Jan 7, 2022 | AN2 Therapeutics | $80.0M Series B | RA Capital Management | Avidity Partners, BVF Partners, Hatteras Venture Partners, Surveyor Capital |
| Jan 1, 2022 | Korro Bio | $120.0M Series B | Joy Ghosh | Atlas Venture, John Hamer, Alexandria Venture Investments, Cormorant Asset Management, Fidelity Management & Research Company, Invus, MP Healthcare Venture Management, NEA, Alex Silverstein, Qiming Venture Partners USA, Sixty Degree Capital, Surveyor Capital, Verition Fund Management, Wu Capital |
| Nov 1, 2021 | HotSpot Therapeutics | $100.0M Series C | Pivotal bioVenture Partners | AbbVie Ventures, Access Biotechnology, Atlas Venture, EQT Life Sciences, Novo Ventures, RiverVest, Roche Venture Fund, Samsara BioCapital, Soffinova Partners, SR One, B Capital Group, CaaS Capital Management, Fouad Azzam, Ph.D., MRL Ventures Fund, Pavilion Capital, Revelation Partners, Tekla Capital Management |
| Nov 1, 2021 | Quell Therapeutics | $160.0M Series B | Fidelity Management & Research Company, Rachel Mears, Wayne Holman, Houman Ashrafian | Lightstone Ventures, Soffinova Partners, SV Health Investors, Judith Hartley MBE, Janus Henderson Investors, Point72, Martin Murphy, Tekla Capital Management |
| Oct 1, 2021 | Skyryse | $200.0M Series B | Fidelity Management & Research Company, Rob Broggi | Alumni Ventures, C2 Investment, Embedded Ventures, Gumi Cryptos Capital, Infinite Capital, Mechanism Capital, Preston-Werner Ventures, Valhalla Capital, WestCap, Kelvin Beachum Jr., Dmitry Balyasny, Laurence A. Tosi, ArrowMark Partners, Eclipse Ventures, Fontinalis Partners, Fortistar, K3 Ventures, Raptor Group, Republic Capital, Rosecliff Ventures, SV Pacific Ventures, Venrock |
| Oct 1, 2021 | Structure Therapeutics | $100.0M Series B | Mark Nathan Lampert | Qiming Venture Partners, Casdin Capital, Cormorant Asset Management, Eight Roads Ventures, F-Prime Capital, Hongshan Capital Group (Sequoia Capital China), Janus Henderson Investors, Lilly Asia Ventures, Sage Partners, Schr"dinger, Stork Capital, Surveyor Capital, Chen Yu, Terra Magnum Capital Partners, TF Capital, Woodline Partners, WuXi AppTec |
| Jul 29, 2021 | Strata Oncology | $90.0M Series C | Wellington Management | Arboretum Ventures, Baird Capital, Cormorant Asset Management, Deerfield Management, Highside Capital Management, Merck, Renaissance Venture Capital Fund |
| Jul 14, 2021 | Ribon Therapeutics | $65.0M Other Equity | Cameron Wheeler, U.S. Venture Partners | AbbVie Ventures, Avego Bioscience Capital, Bristol Myers Squibb, Euclidean Capital, Google Ventures, Johnson & Johnson Innovation, Novartis, Osage University Partners, Peregrine Ventures, Takeda Ventures, The Column Group |
| Jun 30, 2021 | Turntide Technologies | $225.0M Other Equity | — | Breakthrough Energy Ventures, Yishai Lerner, Suvretta Capital Management |
| Jun 25, 2021 | Outdoorsy | $120.0M Debt / Other Equity | ADAR1 Partners, Convivialite Ventures, Monashee Investment Management, Pernod Ricard, Sid Sankaran | Altos Ventures, Greenspring Associates, iAngels, Steven DiPasqluie |
| Jun 1, 2021 | Kindbody | $62.0M Series C | — | Adverb Ventures, Greylock, GV, Erel Margalit, LAUNCH, Offline Ventures, Otherwise Fund, RRE Ventures, Spark Capital, Upfront Ventures, VSC Ventures, Dennis Crowley, Scott Belsky, Bramalea Partners, Perceptive Advisors, Rock Springs Capital |
| May 22, 2021 | HiberCell | $97.4M Debt / Series B | — | ARCH Venture Partners, Bristol Myers Squibb, Hercules Capital, Huizenga Capital Management, Magnetic Ventures, Rene Mora, Mount Sinai Innovation Partners, Tekla Capital Management, Trinitas Capital |
| Mar 1, 2021 | Caribou Biosciences | $120.0M Series C | Farallon Capital Management, Santhosh Palani, PhD, CFA, Jeffrey Long-McGie | 1435 Capital Management, 6th Man Ventures, Afore Capital, DFJ, E1 Ventures, Flucas Ventures, Founders Co-op, Heavybit, Invariantes Fund, Kleiner Perkins, KRM Interests LLC, LombardStreet Ventures, Maverick Capital, Menlo Ventures, Mouro Capital, Necessary Ventures, QED Investors, Robert Bosch Venture Capital, Starbridge Venture Capital, Sterling Equity, William Guo, XStarPartners, Adam Marchick, Andy Rubin, Dylan Taylor, hugo angelmar, Ravi Grover, Richard Cooperstein, Rob Meyerson, Sri Batchu, Sung ho Choi, AbbVie Ventures, Adage Capital Management, Avego Bioscience Capital, Avidity Partners, Heritage Medical Systems, Invus, Janus Henderson Investors, LifeSci Venture Partners, Maverick Ventures, Point72, Pontifax, Tekla Capital Management, The Leukemia & Lymphoma Society |
| Dec 24, 2020 | SomaLogic | $81.0M Series A Extension | Eli Casdin | Amgen Ventures, Boston Millennia Partners, Farallon Capital Management, Fiscus Ventures, Foresite Capital, Intermountain Ventures, Janus Henderson Investors, Logos Capital, Madryn Asset Management, Mossrock Capital, NEC Solution Innovators, Novartis, Redmile Group, Reimagined Ventures, Revelation Partners, Soleus Capital, Roy Smythe, T. Rowe Price Associates, Ziff Capital Partners |
| Aug 18, 2020 | Chinook Therapeutics | $106.0M Other Equity | — | Ally Bridge Group, Apple Tree Partners, Avidity Partners, EcoR1 Capital, Janus Henderson Investors, Northleaf Capital Partners, OrbiMed, Rock Springs Capital, Samsara BioCapital, Sphera Biotech Master Fund, Surveyor Capital, Versant Ventures |
| Nov 1, 2014 | Bionano Genomics | $53.0M Series C | Darren Cai, Campbell Murray | Domain Associates, Questa Capital, Battelle Ventures, Federated Kaufmann Fund, Gund Investment Corporation |
| Apr 16, 2014 | Epirus Biopharmaceuticals | $36.0M Series B | Daotian Fu | 5AM Ventures, Adage Capital Management, Gibralt US, Greenwoods Investment, Montreux Equity Partners, Mousse Partners, TPG Biotech |
